$0.96
-0.0499 (-4.94%)
At Close: Jun 03, 2026
InspireMD Reports Updated Positive CGuard™ EPS Data Presented at VEITH 2019
01:00pm, Tuesday, 26'th Nov 2019
InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today reported on updated registry
InspireMD Offers Updated CGuard Data Presented At VEITH 2019
12:00am, Tuesday, 26'th Nov 2019Is InspireMD, Inc. (NYSEMKT:NSPR) A Volatile Stock?
01:36pm, Wednesday, 13'th Nov 2019
If you own shares in InspireMD, Inc. (NYSEMKT:NSPR) then it's worth thinking about how it contributes to the...
Sign In
Buy NSPR